WordNet

happening or done after a surgical operation; "postoperative complications"; "postoperative care"
the formation or presence of a thrombus (a clot of coagulated blood attached at the site of its formation) in a blood vessel

PrepTutorEJDIC

外科手術後の
血栓症

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 外科患者における静脈血栓塞栓症の予防 prevention of venous thromboembolic disease in surgical patients
2. Mesenteric venous thrombosis in adults
3. 術後発熱 postoperative fever
4. Overview of intestinal ischemia in adults
5. 頸動脈内膜剥離術および頸動脈ステント留置術の麻酔 anesthesia for carotid endarterectomy and carotid stenting

English Journal

Clinical venous thromboembolism following joint surgery: effect of extended thromboprophylaxis on its annual frequency and postoperative pattern over 22 years.

Dahl OE1, Gudmundsen TE, Pripp AH, Aanesen JJ.Author information 11Centre of Medical Science, Education and Innovation, Innlandet Hospital Trust, Brumunddal, Norway.AbstractWe describe annual incidences and 6-month postoperative patterns of clinical venous thromboembolism (VTE) in 9078 patients undergoing major joint surgery in a Scandinavian hospital. In cohort I (1989-1999), low-molecular-weight heparin thromboprophylaxis for 7 to 10 days was uniformly introduced, 5-week thromboprophylaxis becoming routine after total hip replacement (THR), partially applied after hip fracture surgery (HFS), but not used after total knee replacement (TKR) thereafter (2003-2011; cohort II). Mean annual VTE incidence was lower in cohort II than in cohort I after THR and HFS but not after TKR. In cohort I, the cumulative VTE incidence increased sharply during the first 5 postoperative weeks in all groups, subsequently plateauing up to 6 months postsurgery. In cohort II, this incidence remained low and stable during 5 weeks post-THR, rising gradually up to 6 months, with a comparable but less pronounced pattern following HFS but not TKR. In conclusion, the VTE risk after major joint surgery seems to persist after 5- and 1-week prophylaxis in patients undergoing hip surgery and TKR, respectively.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.Clin Appl Thromb Hemost.2014 Mar;20(2):117-23. doi: 10.1177/1076029613499820. Epub 2013 Oct 10.
We describe annual incidences and 6-month postoperative patterns of clinical venous thromboembolism (VTE) in 9078 patients undergoing major joint surgery in a Scandinavian hospital. In cohort I (1989-1999), low-molecular-weight heparin thromboprophylaxis for 7 to 10 days was uniformly introduced, 5-
PMID 24113492

Symptomatic pulmonary embolus after joint arthroplasty: stratification of risk factors.

Parvizi J1, Huang R, Raphael IJ, Arnold WV, Rothman RH.Author information 1Department of Orthopaedic Surgery, Rothman Institute, Thomas Jefferson University Hospital, 925 Chestnut Street, 5th Floor, Philadelphia, PA, 19107, USA.AbstractBACKGROUND: Prophylaxis for pulmonary embolism (PE) after total joint arthroplasty (TJA) presents the clinical dilemma of balancing the risk of postoperative thrombotic risk and anticoagulation-related complications such as bleeding, hematoma formation, and infection. Risk stratification of patients undergoing TJA is needed to tailor prophylaxis based on thrombotic and bleeding risk.
Clinical orthopaedics and related research.Clin Orthop Relat Res.2014 Mar;472(3):903-12. doi: 10.1007/s11999-013-3358-z. Epub 2013 Nov 22.
BACKGROUND: Prophylaxis for pulmonary embolism (PE) after total joint arthroplasty (TJA) presents the clinical dilemma of balancing the risk of postoperative thrombotic risk and anticoagulation-related complications such as bleeding, hematoma formation, and infection. Risk stratification of patients
PMID 24264881

The effects of pre- and postoperative fibrinogen levels on blood loss after cardiac surgery: a systematic review and meta-analysis.

Gielen C1, Dekkers O, Stijnen T, Schoones J, Brand A, Klautz R, Eikenboom J.Author information 1Departments of Cardio-Thoracic Surgery and Thrombosis and Hemostasis, Leiden University Medical Center (LUMC), Leiden, Netherlands.AbstractOBJECTIVES: Fibrinogen concentrate is increasingly used in cardiac surgery when bleeding is anticipated or ongoing. Since randomized clinical studies to support this are lacking, it is relevant to know whether lower fibrinogen levels are associated with excessive bleeding. We performed a systematic review and meta-analysis to define the association between fibrinogen levels and blood loss after cardiac surgery.
Interactive cardiovascular and thoracic surgery.Interact Cardiovasc Thorac Surg.2014 Mar;18(3):292-8. doi: 10.1093/icvts/ivt506. Epub 2013 Dec 6.
OBJECTIVES: Fibrinogen concentrate is increasingly used in cardiac surgery when bleeding is anticipated or ongoing. Since randomized clinical studies to support this are lacking, it is relevant to know whether lower fibrinogen levels are associated with excessive bleeding. We performed a systematic
PMID 24316606